Evidence map›Paper›PMID 42038009›Full record

ArticleBiodesign research2026

Wenhui Niu, Jingxian Zhang, Ying Zhang, Zhongke Sun, Chengwei Li, Yongjun Wei

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biodesign research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wenhui NiuSchool of Pharmaceutical Sciences, Laboratory of Synthetic Biology, State Key Laboratory of Antiviral Drugs, Pingyuan Laboratory, Zhengzhou University, Zhengzhou 450001, People's Republic of China.
Jingxian ZhangSchool of Pharmaceutical Sciences, Laboratory of Synthetic Biology, State Key Laboratory of Antiviral Drugs, Pingyuan Laboratory, Zhengzhou University, Zhengzhou 450001, People's Republic of China.
Ying ZhangSchool of Life Sciences, BBSRC/EPSRC Synthetic Biology Research Centre, Biodiscovery Institute, University of Nottingham, University Park, Nottingham, NG7 2RD, UK.
Zhongke SunSchool of Biological Engineering, Henan University of Technology, Zhengzhou 450001, People's Republic of China.
Chengwei LiZhengzhou Research Base, State Key Laboratory of Cotton Bio-breeding and Integrated Utilization, School of Agricultural Sciences, Zhengzhou University, Zhengzhou 450051, People's Republic of China.
Yongjun WeiSchool of Pharmaceutical Sciences, Laboratory of Synthetic Biology, State Key Laboratory of Antiviral Drugs, Pingyuan Laboratory, Zhengzhou University, Zhengzhou 450001, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medicarpin exhibits multiple pharmacological activities, including antitumor and antibacterial effects. However, its extraction from natural plant sources is limited, and chemical synthesis is complex and costly. Therefore, developing an economical, green, and sustainable medicarpin production method is of great significance. In this study, we achieved the

Indexed as

IsoflavonoidsMedicarpinMetabolic engineeringSaccharomyces cerevisiaeSynthetic biology

Identifiers

PMID42038009
PMCPMC13109337

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.